Then, we simulated the inhibitory effect of PRMT5/MTA inhibitor on GBMs by in vitro and in vivo experiments in which MTAP‐deficient glioma cells coexisted with microglia and neurons with normal MTAP expression. This evidence concerns the gene MTAP and central nervous system cancer.